EUVIMEDEUVIMED entdecken
Crossref

Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein phenotype

John F Marcelletti iD, Branimir I Sikic iD

Cancer Chemotherapy and Pharmacology · 2024

DOI: 10.1007/s00280-024-04656-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2024. Verfasst von John F Marcelletti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Marcelletti Consulting, San Diego, CA, USA. jfmphd@yahoo.com. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Cytarabine, Daunorubicin, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: NIH HHS, NCI NIH HHS, Kanisa Pharmaceuticals, San Diego, CA, USA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteCytarabineDaunorubicinAntineoplastic Combined Chemotherapy ProtocolsATP Binding Cassette Transporter, Subfamily B, Member 1HumansAgedMaleFemaleInfusions, IntravenousMiddle AgedAged, 80 and overPhenotypeDibenzocycloheptenesQuinolines

Stichwörter der Autor:innen

Acute myeloid leukemiaMultidrug resistanceP-glycoproteinZosuquidar

Substanzen

CytarabineDaunorubicinzosuquidar trihydrochlorideATP Binding Cassette Transporter, Subfamily B, Member 1DibenzocycloheptenesQuinolines

Autor:innen und Institutionen

  • Marcelletti Consulting, San Diego, CA, USA. jfmphd@yahoo.com.
  • Clinical and Translational Research Unit, Stanford Cancer Institute, Stanford, CA, USA.

ORCID-Profile: John F Marcelletti, Branimir I Sikic

Förderung

  • NIH HHS
  • NCI NIH HHS
  • Kanisa Pharmaceuticals, San Diego, CA, USA
  • NIH

Zitieren

APA

Marcelletti, J. F., & Sikic, B. I. (2024). Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein phenotype. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04656-6

Vancouver

Marcelletti JF, Sikic BI. Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein phenotype. Cancer Chemotherapy and Pharmacology. 2024. doi:10.1007/s00280-024-04656-6

BibTeX
@article{Marcelletti2024,
  author = {Marcelletti, John F and Sikic, Branimir I},
  title = {Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein phenotype},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2024},
  doi = {10.1007/s00280-024-04656-6}
}
Kostenlos starten →